You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KRAS P.G12C

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

KRAS P.G12C, Pancreatic Cancer Trial in Beijing (JAB-21822)

Not yet recruiting
  • KRAS P.G12C
  • Pancreatic Cancer
  • Beijing, Beijing, China
  • +1 more
Aug 18, 2023

Advanced Solid Tumor Trial in Shanghai (SY-5933)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 16, 2023

Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)

Recruiting
  • Advanced Solid Tumors
  • GEC255 tablets
  • Chengdu, Sichuan, China
    China West Hospital
Mar 14, 2023

KRAS P.G12C, Non Small Cell Lung Cancer Trial in France (Sotorasib 120Mg Tab)

Recruiting
  • KRAS P.G12C
  • Non Small Cell Lung Cancer
  • Sotorasib 120Mg Tab
  • Lyon, France
  • +3 more
Dec 16, 2022

KRAS P.G12C Trial in Worldwide (D3S-001)

Recruiting
  • KRAS P.G12C
  • Detroit, Michigan
  • +12 more
Jan 16, 2023

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

RW Efficacy of Sotorasib in KRAS G12C-mutated Metastatic NSCLC

Recruiting
  • Nsclc
  • KRAS P.G12C
    • Paris, France
    • +2 more
    Aug 9, 2022

    Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Sotorasib, Liposomal Irinotecan

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • (no location specified)
    Feb 11, 2022

    Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +14 more
    • ELI-002 7P
    • (no location specified)
    Feb 3, 2023

    NSCLC Stage III, KRAS P.G12C Trial in Spain (Sotorasib)

    Recruiting
    • Non-small Cell Lung Cancer Stage III
    • KRAS P.G12C
    • Badalona, Barcelona, Spain
    • +19 more
    Jul 6, 2022

    Studying Pathways of Resistance in KRAS-driven Cancers

    Not yet recruiting
    • KRAS P.G12C
    • FoundationOne® Liquid CDx
    • (no location specified)
    Mar 9, 2022

    NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • (no location specified)
    Jun 26, 2023

    KRAS P.G12C, NSCLC, Colorectal Cancer Trial in China (JAB-21822, JAB-3312)

    Recruiting
    • KRAS P.G12C
    • +3 more
    • Beijing, Beijing, China
    • +23 more
    Jun 29, 2022

    NSCLC Trial in China (JAB 21822)

    Recruiting
    • Non-small Cell Lung Cancer
    • JAB 21822
    • Beijing, Beijing, China
    • +20 more
    Sep 26, 2022

    NSCLC, CRC, Solid Tumor Trial in Beijing (JAB-21822)

    Recruiting
    • NSCLC
    • +2 more
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Aug 11, 2021

    NSCLC Stage IV, KRAS P.G12C Trial in Worldwide (Adagrasib)

    Not yet recruiting
    • NSCLC Stage IV
    • KRAS P.G12C
    • Brussels, Belgium
    • +26 more
    Jan 3, 2023

    Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)

    Recruiting
    • Advanced Solid Tumors
    • Kirsten Rat Sarcoma (KRAS) pG12C Mutation
    • Tucson, Arizona
    • +83 more
    Dec 28, 2022

    Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

    Recruiting
    • Advanced or Metastatic Solid Tumor
    • KRAS G12C Mutation
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Nov 2, 2023

    Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)

    Not yet recruiting
    • Non Small Cell Lung Cancer Metastatic
    • +2 more
    • (no location specified)
    Aug 11, 2023

    Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

    Recruiting
    • Solid Tumor, Adult
    • +4 more
    • KRAS-EphA-2-CAR-DC
    • +3 more
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinsese PLA Gereral Hospital
    Nov 29, 2022

    Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

    Not yet recruiting
    • Advanced Solid Tumor
    • Non-small Cell Lung Cancers
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 15, 2023

    Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

    Recruiting
    • Non Small Cell Lung Cancer
    • KRAS Activating Mutation
    • avutometinib (VS-6766)
    • avutometinib (VS-6766) and Defactinib
    • Duarte, California
    • +44 more
    Dec 22, 2022

    Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)

    Recruiting
    • Non Small Cell Lung Cancer
    • Nashville, Tennessee
      Vanderbilt Ingram Cancer Center
    Jun 28, 2022

    Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

    Active, not recruiting
    • Efficacy
    • Oral sotorasib + IV Panitumumab
    • Seoul, Korea, Republic of
      Korea University Anam Hospital
    Aug 14, 2023

    Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

    Not yet recruiting
    • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
    • New York, New York
      NYU Langone Health
    Apr 4, 2023